RARA (Gene)

Synonyms:ENTREZ:5914, HGNC:9864, MIM:180240, NM_000964, NM_001024809, NM_001033603, NM_001145301, NM_001145302, NP_000955, NP_001019980, NP_001138773, NP_001138774, NR1B1, RAR, RARA, XM_005257552, XM_005257553, XM_005257554, XM_011525095, XM_011525096, XM_017024920, XP_005257609, XP_005257610, XP_005257611, XP_011523397, XP_011523398, XP_016880409, retinoic acid receptor alpha
Omim:OMIM:180240
Id:ENSG00000131759
Hgnc:HGNC:9864
Entrez:5914
Description:retinoic acid receptor alpha
This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.[provided by RefSeq, Sep 2010]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RARA's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with RARA.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using RARA.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RARA.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RARA.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.